Louisville, Kentucky based SureGene, LLC utilizes modern genetic technology to discover the underlying genetic basis for psychiatric illnesses and drug response. They develop their genetic discoveries into products (molecular diagnostic tests) used to improve the care of people with serious mental illness.

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics. Existing antibiotic treatments are rapidly becoming obsolete. Doctors increasingly rely on last resort antibiotics such as carbapenems and colistin. As harmful bacteria continue to mutate, this final line of resistance will eventually fail. Helperby’s unique antibiotic technology outsmarts highly resistant bacteria by combining new resistance breakers with old antibiotics to create a whole new generation of therapies. This new lease of life for antibiotics will help to sustain our defence against life threatening superbugs for years to come.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

The Upjohn Company was a pharmaceutical manufacturing firm founded in 1886 in Kalamazoo, Michigan, by Dr. William E. Upjohn, an 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, which were specifically designed to be easily digested. These could be "reduced to a powder under the thumb", a strong marketing argument at the time.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Beijing Harmony Health Medical Diagnostics Co., Ltd. is a Chinese private company located in Beijing. The firm provides medical laboratory services. It was founded in 2010.

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd., established on 1994-03-14, Business range includes tablet(Contains cephalosporins),hard capsule(Contains cephalosporins),cream(Hormone),API(Glibenclamide,furosemide,nalidixic acid,Chlorpromazine Hydrochloride,isosorbide dinitrate,Glucuronolactone,Antipyrine,Aminopyrine,clotrimazole,perphenazine,Diammonium glycyrrhizinate,propantheline bromide,pyrazinamide,ethambutol hydrochloride,sodium cromolyn,Thiapride hydrochloride,Ciprofloxacin Hydrochloride,Flucytosine,Nimodipine,pyrithione hydrochloride,Silymarin,Mexiletine Hydrochloride,Dimethazole,Ketotifen fumarate,Trihexyphenidyl Hydrochloride,Silver sulfadiazine,Tamoxifen Citrate,Lisinopril,Doxycycline Hydrochloride,Ezetimibe,Glycopyrrolate,Formoterol fumarate,Azelastine Hydrochloride,ipratropium bromide),patch,Liniment,Skin care,Hair Cosmetics,Healthy food,oxalic acid,food additives,liquid disinfectant(liquid),Chemical Intermediates(Free of Hazardous Chemicals,Monitor Chemicals,precursor chemicals)Production,Sales;Import and export of goods and technology(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations must be operated after obtaining a license)*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Nuchido Ltd was established to address the growing consumer demand for cosmeceutical products. Cosmeceuticals are the combination of cosmetics and pharmaceuticals, and are cosmetic products with bioactive ingredients that are validated by the science community. A

Enaltec Labs Pvt Ltd., a subsidiary of La Renon Healthcare Pvt Ltd., is an Indian company located in Mumbai. The firm manufactures and supplies pharmaceutical products. It was founded in 2006. Anand Prafulchandra Shah is the current CEO of the firm. La Renon Healthcare Pvt Ltd. acquired Enaltec Labs Pvt Ltd. on January 20, 2022.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Zhengzhou Renhong Pharmaceutical Technology Co., Ltd., established on 2015-11-20, The scope of business includes the development of medical technology,technology transfer;Sales of medical equipment,technical consulting,Technical Services;Technology development of computer hardware and software,technology transfer,technical consulting,Technical Services;Computer Data Processing Services;Computer System Integration Services.

HEXAL is the German generic manufacturer and belongs to the worldwide Sandoz Group with its headquarters in Holzkirchen, Bavaria. HEXAL brings biosimilars to the German market. Biosimilars are high-differentiated products, based on very complex biological molecules. Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques. Many biologics are recombinant proteins and are manufactured using „recombinant DNA“ technology, a process that involves inserting a specific gene into a host cell to produce a particular protein. These complex state-of-the-art molecules represent a distinct regulatory class of medicine compared to traditional, chemically synthesized medicines. In Germany HEXAL employs more then 4.000 people at six sites. The company was founded in 1986 and merged with Sandoz in 2006.

Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product line includes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level.

Jiangsu Yellow River Pharmaceutical Co., Ltd., established on 1999-12-21, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Engage in investment activities with own funds(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)